The legalisation of recreational cannabis may be associated with an increase in fatal motor vehicle collisions based on data from the US, and authors discuss the implications for Canada in an analysis published in Canadian Medical Association Journal.
‘Analyses of data suggest that legalisation of recreational cannabis in United States jurisdictions may be associated with a small but significant increase in fatal motor vehicle collisions and fatalities, which, if extrapolated to the Canadian context, could result in as many as 308 additional driving fatalities annually,’ says Sarah Windle, a researcher from Lady Davis Institute at McGill University.
In Canada, the number of people reporting cannabis consumption increased from 14% in 2018 (before legalisation) to 17% in 2019 (after legalisation). Among cannabis users with a driver’s licence, 13% reported driving within two hours of cannabis consumption, with the number of individuals who reported driving after recent cannabis use increasing from 573,000 to 622,000. An analysis of 2012 data estimated the cost of cannabis-related collisions in Canada to be $1.1 billion annually in societal and economic costs, with drivers aged 34 years and younger responsible for the bulk of the costs.
Healthcare providers can play a role in educating patients, and the authors suggest resources to help.
‘Healthcare professionals have an opportunity to educate patients about the safer use of cannabis products, including advising against cannabis use and driving (especially in combination with alcohol), with a suggested wait time of at least six hours before driving,’ the researchers say.
Government regulation and public awareness could also help reduce the risk of injuries and deaths from driving after cannabis use.
‘Implementation of impaired driving regulations and educational campaigns, including federal THC driving limits and public awareness of these limits, may contribute to the prevention of potential increases in cannabis-impaired driving in Canada,’ the researchers conclude.
Psychreg is mainly for information purposes only; materials on this website are not intended to be a substitute for professional advice. Don’t disregard professional advice or delay in seeking treatment because of what you have read on this website. Read our full disclaimer.